Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT1198 | Organism | Magnaporthe grisea | Magnaporthe grisea | MIC | > | 200 | ug/ml | 14738379 |
NPT1198 | Organism | Magnaporthe grisea | Magnaporthe grisea | EC50 | = | 13 | ug/ml | 14738379 |
NPT20 | Organism | Candida albicans | Candida albicans | IC50 | > | 100 | ug/ml | 1479383 |
NPT20 | Organism | Candida albicans | Candida albicans | IC50 | = | 6 | ug/ml | 1479383 |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | IC50 | = | 430 | nM | 18443109 |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | IC50 | = | 1150 | nM | 18443109 |
NPT3821 | Organism | Alternaria citri | Alternaria citri | MIC | = | 50 | ug/ml | 10775404 |
NPT3821 | Organism | Alternaria citri | Alternaria citri | EC90 | = | 53 | ug/ml | 10775404 |
NPT3660 | Organism | Fusarium avenaceum | Fusarium avenaceum | MIC | = | 25 | ug/ml | 10775404 |
NPT3660 | Organism | Fusarium avenaceum | Fusarium avenaceum | EC90 | = | 7 | ug/ml | 10775404 |
NPT1198 | Organism | Magnaporthe grisea | Magnaporthe grisea | MIC | > | 200 | ug/ml | 10775404 |
NPT1198 | Organism | Magnaporthe grisea | Magnaporthe grisea | EC90 | > | 200 | ug/ml | 10775404 |
NPT3821 | Organism | Alternaria citri | Alternaria citri | EC50 | = | 6 | ug/ml | 10775404 |
NPT3660 | Organism | Fusarium avenaceum | Fusarium avenaceum | EC50 | = | 0.4 | ug/ml | 10775404 |
NPT1198 | Organism | Magnaporthe grisea | Magnaporthe grisea | EC50 | = | 13 | ug/ml | 10775404 |
NPT1198 | Organism | Magnaporthe grisea | Magnaporthe grisea | Inhibition | = | 25.2 | % | 10.1584/jpestics.27.229 |
NPT1198 | Organism | Magnaporthe grisea | Magnaporthe grisea | Inhibition | = | 100 | % | 10.1584/jpestics.27.229 |
NPT1198 | Organism | Magnaporthe grisea | Magnaporthe grisea | Inhibition | = | 76.6 | % | 10.1584/jpestics.27.229 |
NPT1198 | Organism | Magnaporthe grisea | Magnaporthe grisea | Activity | = | 94.3 | % | 10.1584/jpestics.27.229 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC245534 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
0.6486 | Remote Similarity | NPC477519 |
0.6294 | Remote Similarity | NPC318142 |
0.6259 | Remote Similarity | NPC315058 |
0.6242 | Remote Similarity | NPC319334 |
0.6242 | Remote Similarity | NPC317377 |
0.6242 | Remote Similarity | NPC322372 |
0.6242 | Remote Similarity | NPC327517 |
0.6242 | Remote Similarity | NPC321485 |
0.6242 | Remote Similarity | NPC142761 |
0.6154 | Remote Similarity | NPC261730 |
0.6127 | Remote Similarity | NPC313962 |
0.6127 | Remote Similarity | NPC469387 |
0.6119 | Remote Similarity | NPC469423 |
0.6074 | Remote Similarity | NPC313813 |
0.6068 | Remote Similarity | NPC229249 |
0.605 | Remote Similarity | NPC62927 |
0.605 | Remote Similarity | NPC190334 |
0.595 | Remote Similarity | NPC320057 |
0.5906 | Remote Similarity | NPC328914 |
0.5906 | Remote Similarity | NPC475758 |
0.5868 | Remote Similarity | NPC328806 |
0.5859 | Remote Similarity | NPC475791 |
0.5859 | Remote Similarity | NPC13175 |
0.5827 | Remote Similarity | NPC471261 |
0.5811 | Remote Similarity | NPC471256 |
0.5794 | Remote Similarity | NPC90240 |
0.5778 | Remote Similarity | NPC147238 |
0.5769 | Remote Similarity | NPC475149 |
0.5769 | Remote Similarity | NPC471097 |
0.5766 | Remote Similarity | NPC259586 |
0.576 | Remote Similarity | NPC329384 |
0.5748 | Remote Similarity | NPC328779 |
0.5746 | Remote Similarity | NPC298484 |
0.5725 | Remote Similarity | NPC470621 |
0.5725 | Remote Similarity | NPC222481 |
0.5714 | Remote Similarity | NPC6166 |
0.5714 | Remote Similarity | NPC226769 |
0.5714 | Remote Similarity | NPC280946 |
0.5714 | Remote Similarity | NPC467022 |
0.5694 | Remote Similarity | NPC471263 |
0.5691 | Remote Similarity | NPC171116 |
0.5685 | Remote Similarity | NPC324722 |
0.5685 | Remote Similarity | NPC198644 |
0.5685 | Remote Similarity | NPC311244 |
0.5682 | Remote Similarity | NPC166242 |
0.5682 | Remote Similarity | NPC322449 |
0.5682 | Remote Similarity | NPC92874 |
0.5682 | Remote Similarity | NPC62845 |
0.5682 | Remote Similarity | NPC189854 |
0.5669 | Remote Similarity | NPC120887 |
0.5669 | Remote Similarity | NPC469424 |
0.5639 | Remote Similarity | NPC471259 |
0.5639 | Remote Similarity | NPC325900 |
0.5639 | Remote Similarity | NPC10897 |
0.5625 | Remote Similarity | NPC175614 |
0.5621 | Remote Similarity | NPC81079 |
0.5606 | Remote Similarity | NPC314413 |
0.5606 | Remote Similarity | NPC314398 |
0.5606 | Remote Similarity | NPC469895 |
0.5606 | Remote Similarity | NPC239705 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC245534 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
0.719 | Intermediate Similarity | NPD1428 | Phase 2 |
0.696 | Remote Similarity | NPD1805 | Phase 2 |
0.696 | Remote Similarity | NPD1804 | Phase 2 |
0.6899 | Remote Similarity | NPD6936 | Clinical (unspecified phase) |
0.6899 | Remote Similarity | NPD6935 | Phase 3 |
0.6822 | Remote Similarity | NPD869 | Approved |
0.6741 | Remote Similarity | NPD4816 | Clinical (unspecified phase) |
0.6718 | Remote Similarity | NPD6918 | Phase 1 |
0.6613 | Remote Similarity | NPD4743 | Phase 2 |
0.6555 | Remote Similarity | NPD1706 | Clinical (unspecified phase) |
0.648 | Remote Similarity | NPD3161 | Clinical (unspecified phase) |
0.6475 | Remote Similarity | NPD192 | Phase 2 |
0.64 | Remote Similarity | NPD244 | Clinical (unspecified phase) |
0.6341 | Remote Similarity | NPD3121 | Phase 2 |
0.625 | Remote Similarity | NPD285 | Discontinued |
0.6116 | Remote Similarity | NPD9585 | Discontinued |
0.6068 | Remote Similarity | NPD9601 | Approved |
0.605 | Remote Similarity | NPD9603 | Phase 3 |
0.605 | Remote Similarity | NPD9604 | Approved |
0.605 | Remote Similarity | NPD9602 | Phase 3 |
0.6034 | Remote Similarity | NPD9535 | Phase 2 |
0.6034 | Remote Similarity | NPD9534 | Phase 2 |
0.6 | Remote Similarity | NPD1385 | Discontinued |
0.6 | Remote Similarity | NPD3138 | Phase 3 |
0.5956 | Remote Similarity | NPD3139 | Phase 3 |
0.5948 | Remote Similarity | NPD9600 | Approved |
0.5938 | Remote Similarity | NPD7651 | Approved |
0.5906 | Remote Similarity | NPD1455 | Phase 3 |
0.5906 | Remote Similarity | NPD1454 | Phase 3 |
0.5902 | Remote Similarity | NPD267 | Discontinued |
0.5902 | Remote Similarity | NPD9565 | Discontinued |
0.5868 | Remote Similarity | NPD9554 | Approved |
0.5868 | Remote Similarity | NPD9553 | Approved |
0.5854 | Remote Similarity | NPD6943 | Clinical (unspecified phase) |
0.5847 | Remote Similarity | NPD9572 | Clinical (unspecified phase) |
0.5806 | Remote Similarity | NPD1686 | Approved |
0.5794 | Remote Similarity | NPD2621 | Clinical (unspecified phase) |
0.576 | Remote Similarity | NPD215 | Discontinued |
0.5738 | Remote Similarity | NPD301 | Discontinued |
0.5736 | Remote Similarity | NPD2663 | Approved |
0.5726 | Remote Similarity | NPD251 | Approved |
0.5725 | Remote Similarity | NPD2633 | Phase 1 |
0.5714 | Remote Similarity | NPD6237 | Clinical (unspecified phase) |
0.5682 | Remote Similarity | NPD6946 | Approved |
0.5672 | Remote Similarity | NPD6693 | Phase 3 |
0.5669 | Remote Similarity | NPD514 | Clinical (unspecified phase) |
0.5667 | Remote Similarity | NPD205 | Approved |
0.5649 | Remote Similarity | NPD1061 | Clinical (unspecified phase) |
0.5643 | Remote Similarity | NPD7756 | Clinical (unspecified phase) |
0.563 | Remote Similarity | NPD9573 | Phase 2 |
0.562 | Remote Similarity | NPD9654 | Phase 2 |
0.5606 | Remote Similarity | NPD2258 | Approved |
0.5606 | Remote Similarity | NPD2259 | Approved |
0.56 | Remote Similarity | NPD6095 | Approved |
0.56 | Remote Similarity | NPD6094 | Approved |
PubChem CID   | 170012 |
ChEMBL   | CHEMBL476894 |
ZINC   |
Molecular Weight:   | 422.20 |
ALogP:   | -2.4501 |
MLogP:   | 1.9 |
XLogP:   | 0.105 |
# Rotatable Bonds:   | 15 |
Polar Surface Area:   | 217.93 |
# H-Bond Aceptor:   | 13 |
# H-Bond Donor:   | 7 |
# Rings:   | 2 |
# Heavy Atoms:   | 30 |